GSDME and cancer: While the excessive activation of inflammasome-induced pyroptosis in cancer treatment, such as in CAR-T therapy, could also cause serious consequences; The CAR-T cells elicited GSDME–mediated cancer cell pyroptosis and released pyroptosis-related factors.